Literature DB >> 10546938

Macular translocation with retinotomy and retinal rotation for exudative age-related macular degeneration.

L Akduman1, M P Karavellas, J C MacDonald, R J Olk, W R Freeman.   

Abstract

PURPOSE: To determine the effectiveness of macular translocation with retinotomy and retinal rotation in exudative age-related macular degeneration.
METHODS: After written informed consent was obtained, 20 patients underwent macular translocation. We created a 180-degree retinotomy superior, inferior, and temporal to the macula near the equator. The hinged retinal flap was rotated superiorly or inferiorly to place the center of the fovea over an area of healthy retinal pigment epithelium. The retina was flattened under silicone oil and laser photocoagulation was placed.
RESULTS: The fovea was moved 425 to 1,700 microm (965+/-262 microm) superiorly or inferiorly. Follow-up time was 2 to 12 months (median 8 months). Complications included macular pucker (3 eyes), subfoveal hemorrhage (2 eyes), macular hole (1 eye), and progression of cataract in phakic eyes (3 eyes). Thirteen of 20 eyes showed various degrees of proliferative vitreoretinopathy with epiretinal membrane formation over the inferior peripheral retina with the inferior retinal detachment stabilized by the silicone oil. One eye progressed to phthisis bulbi. Initial visual acuity ranged from 20/80 to 20/800 (median 20/150) and final visual acuity ranged from light perception to 20/200 (median 20/1000).
CONCLUSION: The fovea can be moved up to 1,700 microm with retinotomy and retinal rotation; however, there is a high rate of complications. Proliferative vitreoretinopathy is the major complication of this technique and is probably related to the extensive retinotomy and subretinal irrigation inherent in the technique. Other techniques such as scleral shortening may have fewer complications.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10546938     DOI: 10.1097/00006982-199909000-00009

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  6 in total

1.  Retinal pigment epithelium translocation and central visual function in age related macular degeneration: preliminary results.

Authors:  P E Stanga; A Kychenthal; F W Fitzke; A S Halfyard; R Chan; A C Bird; G W Aylward
Journal:  Int Ophthalmol       Date:  2001       Impact factor: 2.031

2.  Long-term results after surgical extraction of subfoveal choroidal neovascular membranes with and without haemorrhage in age-related macular degeneration.

Authors:  Ameli Gabel-Pfisterer; Jessica Laue; Heinrich Heimann; Claudia Jandeck; Ulrich Kellner; Norbert Bornfeld; Michael H Foerster
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-01-09       Impact factor: 3.117

3.  Limited macular translocation with scleral retraction suture.

Authors:  P Sullivan; L Filsecker; J Sears
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

4.  The end of submacular surgery for age-related macular degeneration? A meta-analysis.

Authors:  Christiane I Falkner; Harald Leitich; Florian Frommlet; Peter Bauer; Susanne Binder
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-05-04       Impact factor: 3.117

5.  Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients.

Authors:  Abdullah Ozkaya; Zeynep Alkin; Yalcin Karakucuk; Dilek Yasa; Ahmet Taylan Yazici; Ahmet Demirok
Journal:  ISRN Ophthalmol       Date:  2013-08-29

6.  Is spectral-domain optical coherence tomography essential for flexible treatment regimens with ranibizumab for neovascular age-related macular degeneration?

Authors:  Abdullah Ozkaya; Zeynep Alkin; Hande Mefkure Ozkaya; Alper Agca; Engin Bilge Ozgurhan; Yalcin Karakucuk; Ahmet Taylan Yazici; Ahmet Demirok
Journal:  J Ophthalmol       Date:  2013-11-11       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.